Braidwell’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Braidwell’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,029,901	Closed	-$47.8M	–	97
2023 Q2	$47.8M	Buy	1,029,901 +45,101	+5%	+$1.56M	1.56%	20
2023 Q1	$28.2M	Buy	984,800 +145,725	+17%	+$4.32M	0.93%	41
2022 Q4	$26.2M	Buy	+839,075	New	+$27.4M	0.88%	44

Braidwell's DICE Position: Q3 2023 in Review

Braidwell sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 1,029,901 shares — an estimated $47.8M sold.

Braidwell first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $47.8M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Braidwell reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Braidwell sold 1,029,901 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $47.8M.
Braidwell first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Braidwell's DICE Therapeutics, Inc. Common Stock position peaked at $47.8M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Braidwell's 13F filing for Q3 2023, filed 14 Nov 2023.